PLEASANTON, Calif., Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced the first ever HeartMate 3™ implant ...

PLEASANTON, Calif., /PRNewswire/ -- Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE ...

Lifesaving therapy offers hope for patients with advanced heart failure, serving as a bridge to heart transplantation or long-term therapy. WASHINGTON, Nov. 17, 2025 /PRNewswire/ -- MedStar Washington ...

Abbott is warning of two separate potential safety issues involving its HeartMate 3 implant used to treat advanced heart failure, according to MedTech Dive. The HeartMate 3 is designed as a long-term ...

The procedure was successfully performed at the Army Hospital (Research & Referral) at Delhi Cantonment on a 49-year-old woman, wife of an armed forces' veteran who had been waiting for a heart ...

If headlines about Abbott’s HeartMate 3 problems are giving you déjà vu, you’re not alone. With three recalls related to the left ventricular assist device (LVAD) so far this year, the news is ...

Manufacturer and marketer of medical devices used for mechanical circulatory support, Thoratec Corp.THOR, recently announced that the first HeartMate III implant has been conducted via ...

(Reuters) - Researchers have found a higher rate of dangerous blood clots in patients who received Thoratec Corp's HeartMate II heart pump than had been seen in clinical trials or prior experience, ...

CLEVELAND, OH — Researchers are warning about "unexpectedly" and "abruptly" increased rates of thrombosis with the HeartMate II (Thoratec) left ventricular assist device (LVAD) occurring early after ...

NATIONAL HARBOR, MD — Even Thoratec's HeartMate II left ventricular assist device (LVAD), which had been something of a hit with Dick Cheney and thousands of less famous patients with end-stage heart ...

LAS VEGAS — Patients with elevated central venous pressure shortly after implantation with a continuous-flow left ventricular assist device were at increased risk for gastrointestinal bleeding in a ...